Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2012
10/10/2012CN102716068A Method for carrying therapeutic substances into cells
10/10/2012CN102716067A Vinpocetine injection and production method thereof
10/10/2012CN102716066A Vinpocetine injection and preparation method thereof
10/10/2012CN102716065A Vinpocetine injection and preparation method thereof
10/10/2012CN102716064A Vinpocetine injection and production method thereof
10/10/2012CN102715184A Aqueous olanexidine solution, method of preparing the same, and disinfectant
10/10/2012CN102415988B Wound healing gel and preparation process thereof
10/10/2012CN102258474B Preparation method of self-microemulsifying coenzyme Q10 powdery dry emulsion
10/10/2012CN102228687B Freeze-dried live attenuated hepatitis A vaccine not containing gelatin or human albumin protective agent and preparation method for freeze-dried live attenuated hepatitis A vaccine
10/10/2012CN102210690B Fasudil hydrochloride injection composition and preparation method thereof
10/10/2012CN102204927B Medicament for treating endoplasmic reticulum (ER) breast cancer
10/10/2012CN102166362B Porcine reproductive and respiratory syndrome live vaccine heat-resistant freeze-drying protective agent and preparation method thereof
10/10/2012CN102166206B Liquid oseltamivir phosphate composition
10/10/2012CN102138896B Clofarabine injection and preparation method thereof
10/10/2012CN102127172B Water-soluble coenzyme Q 10 compound and preparation method thereof
10/10/2012CN102085182B Sinomenine hydrochloride slow-release injection and preparation method thereof
10/10/2012CN102085180B Dobutamine hydrochloride injection and preparation method thereof
10/10/2012CN102078289B Cream for promoting tissue regeneration and astringing wound and preparation method thereof
10/10/2012CN102068702B Lactosyl-norcantharidin phospholipid compound and preparation method thereof
10/10/2012CN102058553B Acyclovir sustained release tablet and preparation method thereof
10/10/2012CN102038661B Oleanolic acid osmotic pump tablet and preparation method thereof
10/10/2012CN102030871B Polyethylene glycol block biodegradable polyester comb-type graft copolymer, and preparation method and application thereof
10/10/2012CN102028958B Composite tumor gene vaccine taking bacterial nano magnetosome as carrier and preparation method thereof
10/10/2012CN102021074B Thermally sensitive plant-aromatic controlled-release granules and preparation method thereof
10/10/2012CN102000020B Novel micro-needle patch containing degradable polymer and preparation method thereof
10/10/2012CN101947212B Micro-embedded medicament carrier and preparation method thereof
10/10/2012CN101921361B Polyacrylic resin latex for enteric medicine coating material and preparation method thereof
10/10/2012CN101914198B TPGS-b-(PCL-ran-PGA) copolymer and preparation method and application thereof
10/10/2012CN101906156B Structures and application of bifunctional protein and derivatives of bifunctional protein
10/10/2012CN101899105B Recombinant erythropoietin and preparation method thereof
10/10/2012CN101869570B Ciclesonide contained pharmaceutical composition for application to mucosa
10/10/2012CN101816639B Tablets of mosapride citrate and preparation method thereof
10/10/2012CN101795694B Injection, injection solution and injection kit preparation
10/10/2012CN101745095B Composition of reduced glutathione and sodium carbonate or sodium bicarbonate
10/10/2012CN101732260B Granules of cefetamet pivoxil hydrochloride and preparation method thereof
10/10/2012CN101705529B Composite superfine fibre membrane of biologic compatible shell core structure and preparation method thereof
10/10/2012CN101625919B Preparation method of meso-porous nanometer magnetic material
10/10/2012CN101605531B Ophthalmic compositions containing a synergistic combination of three polymers
10/10/2012CN101596311B Stable kallikrein-1 injection
10/10/2012CN101573105B 包装件 Package
10/10/2012CN101524536B Japanese encephalitis vaccine prepared by human embryonic lung fibroblasts and preparation method thereof
10/10/2012CN101491681B Medicine containing PEG human growth hormone conjugate and use thereof
10/10/2012CN101405031B Formulations for parenteral delivery of compounds and uses thereof
10/10/2012CN101400670B Novel pyridine derivative having anti-helicobacter pylori activity
10/10/2012CN101336907B Patch and patch preparation
10/10/2012CN101305052B Interpenetrating networks, and related methods and compositions
10/10/2012CN101287484B Binding agents which inhibit myostatin
10/10/2012CN101267841B Process for preparing maytansinoid antibody conjugates
10/10/2012CN101247805B Tablet containing hardly soluble active ingredient
10/10/2012CN101244064B Pharmaceutical combination for preventing and treating motion sickness and preparations thereof
10/10/2012CN101229127B Liposome preparation
10/10/2012CN101217982B Drug-containing photocrosslinked hyaluronic acid derivative gel
10/10/2012CN101137356B Adhesive and plaster
10/10/2012CN101137355B Non-fibrous transdermal therapeutic system and method for its production
10/10/2012CN101129368B Freeze-dried powder needle containing lansoprazole
10/10/2012CN101128487B Bispecific domain antibodies targeting serum albumin and GLP-1 or PYY
10/10/2012CN101083907B Compositions and methods for topical diagnostic and therapeutic transport
10/10/2012CN101039656B Enteric nutritional supplement
10/09/2012US8283444 Non-viral delivery of compounds to mitochondria
10/09/2012US8283414 Compositions comprising modified collagen and uses therefor
10/09/2012US8283384 Adhesive complex coacervates and methods of making and using thereof
10/09/2012US8283381 Conjugated psychotropic drugs and uses thereof
10/09/2012US8283327 Palatinose for enhancing dietary supplement and pharmaceutical delivery
10/09/2012US8283320 Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostasis
10/09/2012US8282954 Method for manufacturing edible film
10/09/2012US8282913 Ion binding polymers and uses thereof
10/09/2012US8282909 Pharmaceutical composition for topical application of poorly soluble compounds
10/09/2012CA2560432C Pseudo-thermosetting neutralized chitosan composition forming a hydrogel and a process for producing the same
10/09/2012CA2555467C Process for the production of conjugates from polysaccharides and polynucleotides
10/09/2012CA2481700C Triglyceride fat
10/09/2012CA2476901C Anti-ccr5 antibody
10/09/2012CA2455830C Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans
10/09/2012CA2451040C Gum resin for topical administration of pharmacologically active agents
10/09/2012CA2448622C Proliposomal drug delivery system
10/09/2012CA2403501C Non-invasive gene targeting to the brain
10/09/2012CA2243845C Biologically active and particularly peptide molecules having a potentiating effect on growth hormone biological activity
10/04/2012WO2012135630A2 Crk-a novel target for cancer therapy
10/04/2012WO2012135592A2 Theranostic imaging agents and methods of use
10/04/2012WO2012135588A2 Methods of treating serosal cancer
10/04/2012WO2012135562A2 Polymer conjugates targeting cells and methods related thereto
10/04/2012WO2012135559A1 Menthol liquids composition
10/04/2012WO2012135522A2 Process for manufacturing conjugates of improved homogeneity
10/04/2012WO2012135517A2 Preparation of maytansinoid antibody conjugates by a one-step process
10/04/2012WO2012135422A2 Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics
10/04/2012WO2012135343A1 Endopeptidase treatment of sexual dysfunction disorders
10/04/2012WO2012135304A1 Vagal nerve-based disorders
10/04/2012WO2012135010A2 Osmotic mediated release synthetic nanocarriers
10/04/2012WO2012134902A1 Endopeptidase and neurotoxin combination treatment of dystonia, cerebral palsy and migraine
10/04/2012WO2012134901A1 Re-targeted endopeptidases for use in the treatment of skin diseases
10/04/2012WO2012134540A2 Injectable synthetic pur composite
10/04/2012WO2012134380A1 Pouch containing nicotine in free salt form
10/04/2012WO2012134351A1 Clathrate complexes of beta-cyclodextrin and 5-hydroxy-4-aminomethyl-1-cyclohexyl (or cycloheptyl)-3-alkoxycarbonyl indole derivative, which exhibit an anti-viral effect, and methods for producing said complexes
10/04/2012WO2012133997A1 Polysorbitol-based osmotically active transporter and gene therapy using same
10/04/2012WO2012133817A1 Vesicle composition
10/04/2012WO2012133648A1 Novel preparation technique for higher-order structure that exhibits anti-cellular effect
10/04/2012WO2012133554A1 Fat emulsion containing prostaglandin
10/04/2012WO2012133492A1 Ointment with excellent formulation stability
10/04/2012WO2012133409A1 Externally used drug kit
10/04/2012WO2012133408A1 Film-shaped externally used drug composition
10/04/2012WO2012133407A1 Film-shaped externally used drug composition
1 ... 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 ... 1712